These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32876952)

  • 1. A review on medical management of inflammatory bowel disease during the coronavirus disease 2019 pandemic.
    Chela H; Pasha SB; Wan XF; Ghouri YA
    J Gastroenterol Hepatol; 2021 Apr; 36(4):918-926. PubMed ID: 32876952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives' on COVID-19 and health care service during the pandemic.
    Moum KM; Moum B; Opheim R
    Scand J Gastroenterol; 2021 May; 56(5):545-551. PubMed ID: 33771086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician.
    Chebli JMF; Queiroz NSF; Damião AOMC; Chebli LA; Costa MHM; Parra RS
    World J Gastroenterol; 2021 Mar; 27(11):1022-1042. PubMed ID: 33776370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal inflammatory bowel disease management during the global coronavirus disease 2019 pandemic.
    El Ouali S; Rubin DT; Cohen BL; Regueiro MD; Rieder F
    Curr Opin Gastroenterol; 2021 Jul; 37(4):313-319. PubMed ID: 33859104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [KASID Guidance for Clinical Practice Management of Adult Inflammatory Bowel Disease during the COVID-19 Pandemic: Expert Consensus Statement].
    Park YE; Lee YJ; Chang JY; Song HJ; Kim DH; Yang YJ; Kim BC; Lee JG; Yang HC; Choi M; Kim SE; Myung SJ;
    Korean J Gastroenterol; 2021 Aug; 78(2):105-116. PubMed ID: 34446633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 and inflammatory bowel disease: A pathophysiological assessment.
    Yang C; Xiao SY
    Biomed Pharmacother; 2021 Mar; 135():111233. PubMed ID: 33433350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence.
    Esposito S; Caminiti C; Giordano R; Argentiero A; Ramundo G; Principi N
    Front Immunol; 2022; 13():933774. PubMed ID: 35812420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of Societal Recommendations Regarding Management of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic.
    Grossberg LB; Pellish RS; Cheifetz AS; Feuerstein JD
    Inflamm Bowel Dis; 2021 May; 27(6):940-946. PubMed ID: 32619010
    [No Abstract]   [Full Text] [Related]  

  • 9. Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.
    Aysha AA; Rentsch C; Prentice R; Johnson D; Bryant RV; Ward MG; Costello SP; Lewindon P; Ghaly S; Connor SJ; Begun J; Christensen B
    Intern Med J; 2020 Jul; 50(7):798-804. PubMed ID: 32656985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting.
    Siegel CA; Melmed GY; McGovern DP; Rai V; Krammer F; Rubin DT; Abreu MT; Dubinsky MC; ;
    Gut; 2021 Apr; 70(4):635-640. PubMed ID: 33472895
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future.
    Viganò C; Mulinacci G; Palermo A; Barisani D; Pirola L; Fichera M; Invernizzi P; Massironi S
    World J Gastroenterol; 2021 Sep; 27(33):5520-5535. PubMed ID: 34588749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Turkish IBD Organization's Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic.
    Törüner M; Kalkan İH; Akyüz F; Tezel A; Çelik AF
    Turk J Gastroenterol; 2021 Jun; 32(6):488-492. PubMed ID: 34405814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 in patients with inflammatory bowel disease.
    Anikhindi SA; Kumar A; Arora A
    Expert Rev Gastroenterol Hepatol; 2020 Dec; 14(12):1187-1193. PubMed ID: 32856955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients.
    Spencer EA; Klang E; Dolinger M; Pittman N; Dubinsky MC
    Inflamm Bowel Dis; 2021 Oct; 27(11):1862-1864. PubMed ID: 34427638
    [No Abstract]   [Full Text] [Related]  

  • 15. Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers.
    Stallmach A; Sturm A; Blumenstein I; Helwig U; Koletzko S; Lynen P; Schmidt C; Dignass A; Kucharzik T;
    Z Gastroenterol; 2020 Oct; 58(10):982-1002. PubMed ID: 33036052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease.
    Scucchi L; Neri B; Sarmati L; Mossa M; Sena G; Massoud R; Petruzziello C; Musumeci M; Marafini I; Calabrese E; Lolli E; Bernardini S; Andreoni M; Monteleone G; Biancone L
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2418-2424. PubMed ID: 33755981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expert Opinions on the Current Therapeutic Management of Inflammatory Bowel Disease during the COVID-19 Pandemic: Japan IBD COVID-19 Taskforce, Intractable Diseases, the Health and Labor Sciences Research.
    Nakase H; Matsumoto T; Matsuura M; Iijima H; Matsuoka K; Ohmiya N; Ishihara S; Hirai F; Wagatsuma K; Yokoyama Y; Hisamatsu T
    Digestion; 2021; 102(5):814-822. PubMed ID: 32892197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection.
    Dvornikova KA; Bystrova EY; Churilov LP; Lerner A
    Mol Biol Rep; 2021 Jul; 48(7):5745-5758. PubMed ID: 34296352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID].
    Lee YJ; Kim SE; Park YE; Chang JY; Song HJ; Kim DH; Yang YJ; Kim BC; Lee JG; Yang HC; Choi M; Myung SJ;
    Korean J Gastroenterol; 2021 Aug; 78(2):117-128. PubMed ID: 34446634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.